Chetangupta wrote:
Reducing the serotonin deficit caused by a breakdown in the passage of serotonin molecules from the presynaptic cell to receptors on the postsynaptic cell has been identified as a successful treatment for clinical depression for many individuals. A new series of drugs, Selective Serotonin Reuptake Inhibitors, prevent the presynaptic cell from re-uptaking serotonin, thereby allowing normal amounts of serotonin to reach the receptors on the postsynaptic cell.
Which of the following can be correctly inferred from the above statements?
If too much serotonin is released to the receptors, a person will feel extremely euphoric.
Taking a Selective Serotonin Reuptake Inhibitor is currently the only successful treatment for clinical depression.
Individuals who have normal levels of serotonin uptake do not run the risk of suffering from depression.
By not taking a Selective Serotonin Reuptake Inhibitor, individuals with depression run the risk of depleting their serotonin levels.
Taking Selective Serotonin Reuptake Inhibitors reduces the incidence of depression in some people.
Any suggestions on how to approach such questions. I was not able to make much out of this, so just made a informed guess (chose E
) and moved on.
I got to C, and this is how I reached to the answer choice
reducing S -> successful treatment for clinical depression in many individuals.
new drug -> SSRI -> prevent from reaching again high levels of S.
thus, SSRI -> allows the "normal" amount of S to reach the receptors.
A. we do not have any information about being euphoric. out.
B. THE ONLY - way too extreme. the argument says that it has been identified as a treatment. not that it is the only treatment.
C. reducing S is a way to treat. but it might be the case that some people with depression do not have high level of S.
D. is too extreme.
E. reduces in some people. written in the same language as the argument...
E for me.